Literature DB >> 33234908

Preoperative Nutritional Status and Risk for Subsyndromal Delirium in Older Adults Following Joint Replacement Surgery.

Dawn L Denny1,2,3, Tanya Trotter1,2,3, Glenda Lindseth1,2,3.   

Abstract

BACKGROUND: Subsyndromal delirium following surgery in older adults is related to increased lengths of hospital stay and increased admissions to long-term care. Impaired nutrition increases risk for delirium, but its relationship to subsyndromal delirium remains unclear.
PURPOSE: This correlational study examined the relationship between nutritional status and subsyndromal delirium in older adults.
METHODS: Assessments for subsyndromal delirium in 53 adults 65 years or older were completed for three consecutive days following joint replacement surgery. Relationships between nutritional status and subsyndromal delirium were analyzed. Level of significance for all tests was set at p ≤ .05.
RESULTS: Participants' scores from the Mini Nutritional Assessment screen were significantly related (p = .05) to subsyndromal delirium severity after accounting for variability posed by age and cognition status.
CONCLUSION: When preoperative risk assessment of older adults indicates nutritional risk, preoperative optimization may improve effectiveness of delirium prevention efforts.

Entities:  

Mesh:

Year:  2020        PMID: 33234908     DOI: 10.1097/NOR.0000000000000710

Source DB:  PubMed          Journal:  Orthop Nurs        ISSN: 0744-6020            Impact factor:   0.913


  2 in total

Review 1.  Brain Prehabilitation for Oncologic Surgery.

Authors:  Neil Daksla; Victoria Nguyen; Zhaosheng Jin; Sergio D Bergese
Journal:  Curr Oncol Rep       Date:  2022-07-28       Impact factor: 5.945

2.  Knowledge, attitudes and practices of ICU nurses regarding subsyndromal delirium among 20 hospitals in China: a descriptive cross-sectional survey.

Authors:  Huanmin Xing; Shichao Zhu; Shiqing Liu; Ming Xia; Mengjuan Jing; Guangyan Dong; Weiwei Ni; Liming Li
Journal:  BMJ Open       Date:  2022-09-20       Impact factor: 3.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.